E Fund Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,400
| Closed | -$250K | – | 323 |
|
|
2024
Q1 | $250K | Buy |
+7,400
| New | +$250K | 0.02% | 300 |
|
|
2023
Q3 | – | Sell |
-8,523
| Closed | -$244K | – | 295 |
|
|
2023
Q2 | $244K | Sell |
8,523
-550
| -6% | -$15.7K | 0.02% | 250 |
|
|
2023
Q1 | $217K | Buy |
+9,073
| New | +$217K | 0.02% | 283 |
|
|
2022
Q4 | – | Sell |
-12,713
| Closed | -$188K | – | 337 |
|
|
2022
Q3 | $188K | Sell |
12,713
-1,022
| -7% | -$15.1K | 0.02% | 311 |
|
|
2022
Q2 | $216K | Buy |
13,735
+1,825
| +15% | +$28.7K | 0.02% | 288 |
|
|
2022
Q1 | $321K | Buy |
+11,910
| New | +$321K | 0.01% | 179 |
|